Synthesis and evaluation of new pyrazoline-thiazole derivatives as monoamine oxidase inhibitors
JOURNAL OF HETEROCYCLIC CHEMISTRY, vol.56, no.11, pp.3000-3007, 2019 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 56 Issue: 11
- Publication Date: 2019
- Doi Number: 10.1002/jhet.3694
- Journal Name: JOURNAL OF HETEROCYCLIC CHEMISTRY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Index Chemicus (IC)
- Page Numbers: pp.3000-3007
- Bilecik Şeyh Edebali University Affiliated: No
Abstract
A novel series of 1,3,5-trisubstituted-2-pyrazoline derivatives (4a-4k) was synthesized and their chemical structures characterized by H-1 NMR, C-13 NMR, and mass spectroscopy. These compounds were evaluated as inhibitors for of type A and type B monoamine oxidase (MAO) enzymes. The most common inhibitors of MAO enzymes used to treat depression and anxiety such as selegiline and moclobemide drugs were used as reference agents. A result of biological evaluation of these compounds revealed compounds 4c, 4d, and 4i as potent and selective MAO A inhibitors. The most active compound 4i, which is 2,4-dimethoxy at phenyl ring, showed strong inhibitory activity at MAO A (IC50 of 0.0445 +/- 0.0018 mu M). Furthermore, compounds 4c and 4d showed significant inhibition profile on MAO A with the IC50 values 0.1423 +/- 0.0051 mu M and 0.2148 +/- 0.0067 mu M, respectively.